Advertisement

Topics

Sarah Cannon Blood Cancer Network Company Profile

06:41 EDT 20th October 2017 | BioPortfolio

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kingdom. Its network conducts over 850 transplants annually and has treated more than 9,500 patients since the inception of our first program. Through its commitment to the highest level of quality standards, infrastructure, training and research, the Sarah Cannon Blood Cancer Network provides an unparalleled experience for patients seeking treatment. For more information about the Blood Cancer Network and Sarah Cannon’s full suite of oncology services, please visit: sarahcannon.com.


News Articles [3930 Associated News Articles listed on BioPortfolio]

Putnam Community Medical Center, Integrated Oncology Network, and Kuruvilla Oncology Announce Affiliation in Palatka Florida

Hospital moves forward to partner with Integrated Oncology Network and Kuruvilla Oncology to establish the “Cancer Center of Putnam” Palatka, Fla. (PRWEB) September 25, 2017 Putnam Community Medi...

Simple CT scanning procedure shows measuring blood flow can predict effectiveness of ovarian cancer treatment

Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer. A multi-c...

Simple blood test could detect cancer symptoms a decade before they become dangerous – Netdoctor

NetdoctorSimple blood test could detect cancer symptoms a decade before they become dangerousNetdoctorA universal blood test that detects cancer years before symptoms appear is on the horizon, promisi...

How blood vessels slow down and accelerate tumour growth

Cancer cells have an enormous need for oxygen and nutrients. Therefore, growing tumors rely on the simultaneous growth of capillaries, the fine branching blood vessels that form a supply network for ...

06.12.12 -- Breakthrough Blood-Based Cancer Gene Testing Technology Launched

06/12/12Laboratory Network.com Newsletter

What Is Glioblastoma? McCain's Brain Tumor Is an Aggressive Type of Cancer

A glioblastoma is a highly malignant form of cancer that spreads quickly due to its association with a large network of blood vessels in the brain.

Researchers uncover new mechanism that promotes growth of blood vessels in tumors

Cancer cells have an enormous need for oxygen and nutrients. Therefore, growing tumors rely on the simultaneous growth of capillaries, the fine branching blood vessels that form a supply network for t...

New antibody uses 1-2 punch to potentially treat blood cancers

Researchers have developed a two-pronged approach to blood cancer treatment:  attacking cancer cells directly and/or driving them from the nurturing bone marrow environment into the peripheral blood ...

PubMed Articles [9983 Associated PubMed Articles listed on BioPortfolio]

ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.

ABO blood type is an inherited characteristic. The associations between ABO blood type and risk of all cancer and specific cancers were examined in a prospective cohort study of 18,244 Chinese men enr...

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.

The Effects on Children's Anxiety and Quality of Life of a Psychoeducational Program for Families Living With Parental Cancer and Their Network: A Randomized Controlled Trial Study.

Families living with parental cancer report lack of social support. The Cancer PEPSONE Program (CPP) was developed to bridge the gap between the families and their network.

Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society.

The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were s...

Blood type, ABO genetic variants, and ovarian cancer survival.

Blood type A and the A1 allele have been associated with increased ovarian cancer risk. With only two small studies published to date, evidence for an association between ABO blood type and ovarian ca...

Clinical Trials [11321 Associated Clinical Trials listed on BioPortfolio]

SCRI TISSUE TESTING REGISTRY

Sarah Cannon Research Institute (SCRI) is committed to improvement and excellence in clinical research and correlative science. To this end, the SCRI Oncology Research Consortium will coll...

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

In this study, patients with metastatic HER2-negative breast cancer will receive treatment with ixabepilone and sorafenib until disease progression or unacceptable toxicity occurs. The Pha...

Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)

GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variatio...

Family Blood Pressure Program - GenNet Network

To identify new genetic loci regulating blood pressure in hypertensive rats and in case-controls from relevant human populations. The study consists of a four grant network, which in turn...

Assessing Community Cancer Care After Insurance ExpanSionS

This innovative and timely study will measure the impact of Affordable Care Act (ACA) Medicaid expansions on cancer screenings and preventive services. To assess this natural policy experi...

Companies [2580 Associated Companies listed on BioPortfolio]

Sarah Cannon Blood Cancer Network

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kin...

The Sarah Cannon Blood Cancer Network

Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including blood and marrow...

Sarah Cannon Research Institute (SCRI)

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the world’s leading clinical res...

Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research program...

The Multiple Myeloma Research Consortium

The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myelo...

More Information about "Sarah Cannon Blood Cancer Network" on BioPortfolio

We have published hundreds of Sarah Cannon Blood Cancer Network news stories on BioPortfolio along with dozens of Sarah Cannon Blood Cancer Network Clinical Trials and PubMed Articles about Sarah Cannon Blood Cancer Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sarah Cannon Blood Cancer Network Companies in our database. You can also find out about relevant Sarah Cannon Blood Cancer Network Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record